Clinical Significance of Biofilm on Silicone Tubes Removed From Patients With Nasolacrimal Duct Stenosis

2018 ◽  
Vol 29 (2) ◽  
pp. 462-465 ◽  
Author(s):  
Sung Hyun Kim ◽  
Choul Yong Park ◽  
Sang Won Hwang ◽  
Minwook Chang
2019 ◽  
Vol 33 (1) ◽  
pp. 95 ◽  
Author(s):  
Yeonji Jang ◽  
Namju Kim ◽  
Keun-Wook Lee ◽  
Ho-Kyung Choung ◽  
Sang In Khwarg

2016 ◽  
Vol 67 (2) ◽  
pp. 109-113
Author(s):  
Shigechika KOHASHI ◽  
Hideya ISAI ◽  
Tomotaka TOMIYAMA ◽  
Toshihiko NAKASHIMA ◽  
Makoto TAKEDA

2008 ◽  
Vol 22 (6) ◽  
pp. 629-634 ◽  
Author(s):  
Roee Landsberg ◽  
Oren Cavel ◽  
Yoram Segev ◽  
Avi Khafif ◽  
Dan M. Fliss

Background It is well documented that inverted papillomas (IP) have a localized attachment site. Still, instead of concentrating on the attachment site, endoscopic surgeons often perform an extended resection similar to the one achieved after external surgery. Objective Our objective was to evaluate an attachment-oriented endoscopic surgical strategy and to determine IP attachment diameter and location. Methods A prospective study was conducted. Thirty-three consecutive patients who underwent endoscopic IP excision (2001-2007) were enrolled. Thirty patients had adequate follow-up. Attachment diameters were measured in 25/33 patients. Surgery included debulking, identifying the precise mucosal attachment site, subperiosteal dissection and excision of the attachment, frozen section control, and resection/drilling of underlying bone. Results The mean measured attachment diameter (n = 25) was 8.4 ± 6 mm (range, 3-23 mm). Attachment locations included maxillary sinus (39%), ethmoid sinus (21%), nasal cavity (21%), frontal sinus (6%), sphenoid sinus (6%), lamina papyracea (3%), and cribriform plate (3%). The mean follow-up (n = 30) was 40 ± 21 months. Three patients had Krouse stage 1, 10 patients had stage 2, and 17 patients had stage 3. Nine patients had undergone previous surgeries. After attachment-oriented endoscopic surgery, three patients had persistent disease. Nasolacrimal duct stenosis was the only complication (n = 1). Conclusion Even advanced IP have small attachments. Their Identification facilitates efficacious resection with minimal morbidity.


2019 ◽  
Author(s):  
Yan-hui Cui ◽  
Cheng-yue Zhang ◽  
Wen Liu ◽  
Qian Wu ◽  
Gang Yu ◽  
...  

Abstract Purpose: To investigate the therapeutic effectiveness and safety of endoscopic dacryocystorhinostomy (EN-DCR) to treat congenital nasolacrimal canal dysplasia (CNCD). Methods: Forty children (50 eyes) with congenital nasolacrimal duct obstruction (CNLDO) and lacrimal bony dysplasia, including 8 with bony atresia (10 eyes) and 32 with bony stenosis (40 eyes), were recruited in this retrospective study. Standardized EN-DCR was performed in all cases. The post-operative observations included relief of symptoms, fluorescein dye disappearance test (FDDT), syringing of lacrimal passages and anastomotic patency under nasal endoscopy. Patients were followed up for 8-18 months. Results: The standardized EN-DCR surgery had a success (cure and improvement) rate of 100%, including a cure rate of 82% and an improvement rate of 18%. The cure rate of 40 bony nasolacrimal duct stenosis was 82.5% and 10 bony nasolacrimal duct atresia was 80%. Statistical analysis showed that nether the receipt of other treatments before surgery nor the type of bony nasolacrimal duct dysplasia affected the cure rate. No significant complications were observed during the post-operative follow-up, except for four cases (4 eyes) that suffered middle turbinate and nasal mucosal adhesion and two cases with sinusitis. Conclusions: CNCD is a type of CNLDO that does not respond to conservative and conventional treatment. EN-DCR provides a safe and effective treatment for children with CNCD. It has a high success rate with a low incidence of complications.


2019 ◽  
Vol 09 (04) ◽  
pp. 161-164
Author(s):  
Brian Conahan ◽  
Yan Saoirse ◽  
Samiksha Fouzdar Jain ◽  
Donny Suh

2005 ◽  
Vol 21 (2) ◽  
pp. 142-147 ◽  
Author(s):  
Mohsen Bahmani Kashkouli ◽  
Roxanne C. Kempster ◽  
Gavin D. Galloway ◽  
Bijan Beigi

Sign in / Sign up

Export Citation Format

Share Document